of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27 Notification of the resignation of Chairman of the Audit

Committee, Appointment of Audit Committee, Appointment of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27

the Extrao General Hosp ober 2, 2017 rdinary Gene mber 13, 2017 ention Hote st of shareh 7. 1/2017 will b der and cert holders No.2 rd deems ap Meeting of S ider the app 0-1 Soi Ladp ng Limited (r ard

for greater clarity the qualifications of the IPO applicant in the part of non-involvement in any illegal business by excluding any insignificant misdemeanor or any wrongdoing not directly related to

business. The revision would exclude any insignificant misdemeanor or any wrongdoing not directly related to the issuer’s core business. In any event, the issuer must not operate business in such a way that

morandum of gards, the Exe mittee and/or emorandum o e any necessa ved to propos e of registere ht 803,155,21 mber of 267,7 morandum of A olutions of the rdinary Gene he Purpose o f Thailand eport Form (F

December 3, 2018 Re: Assistance financial to the related companies. To: Director and Manager of Stock Exchange of Thailand According to the Board of meeting of D.T.C. Industries Plc. No. 6/2018 on

acquisition as per details in Attachment 2. As Item 3 and Item 4 are related agenda and also related to the business acquisition, therefore, if Item 3 has not been approved by the Shareholders' Meeting, it is

and Drug Administration (CFDA), which took around 2 months, that we have got CFDA in early 2018. Sales by product category Consolidated financial statements For the three months period ended March 31

persons ) and related services i.e. registration with Food and Drug Administration (FDA), trademark permission, product and packaging design, and brand building etc. to customers who are business operator